Decision-making and quality of life in older adults with acute myeloid leukemia or advanced myelodysplastic syndrome-Reference-Cited by-同舟云学术

Decision-making and quality of life in older adults with acute myeloid leukemia or advanced myelodysplastic syndrome

Published:2004-02-05 Issue:4 Volume:18 Page:809-816
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Sekeres M A,Stone R M,Zahrieh D,Neuberg D,Morrison V,De Angelo D J,Galinsky I,Lee S J

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/2403289.pdf

Reference54 articles.

1. Ries L, Eisner M, Kosary C (eds) SEER Cancer Statistics Review, 1973–1999. Bethesda, Maryland: National Cancer Institute, 2002.

2. Parkin D, Muir C, Whelan S, Gao Y, Ferlay J, Powell J . Cancer Incidence in Five Continents, World Health Organization, International Agency for Research on Cancer, Vol. VI Lyon, France: IARC Scientific Publication No. 120, 1992.

3. Estey EH, Keating MJ, McCredie KB, Bodey GP, Freireich EJ . Causes of initial remission induction failure in acute myelogenous leukemia. Blood 1982; 60: 309–315.

4. Estey EH . Treatment of acute myelogenous leukemia and myelodysplastic syndromes. Semin Hematol 1995; 32: 132–151.

5. Bishop JF, Lowenthal RM, Joshua D, Matthews JP, Todd D, Cobcroft R et al. Etoposide in acute nonlymphocytic leukemia. Australian Leukemia Study Group. Blood 1990; 75: 27–32.

Cited by 172 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Decitabine in older patients with AML: quality of life results of the EORTC-GIMEMA-GMDS-SG randomized phase 3 trial;Blood;2024-08-01

2. TP53 Mutations in Acute Leukemias and Myelodysplastic Syndromes: Insights and Treatment Updates;American Society of Clinical Oncology Educational Book;2024-06

3. Palliative radiotherapy in the older adult;Palliative Radiation Oncology;2024

4. Expressive writing to address distress in hospitalized adults with acute myeloid leukemia: a pilot randomized clinical trial;Journal of Psychosocial Oncology;2023-12-22

5. Glasdegib plus intensive or non-intensive chemotherapy for untreated acute myeloid leukemia: results from the randomized, phase 3 BRIGHT AML 1019 trial;Leukemia;2023-08-21